Drug Type Therapeutic vaccine |
Synonyms Algenpantucel-L (USAN), HAPa, HyperAcute Pancreas + [2] |
Target- |
Mechanism Immunostimulants |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
RegulationOrphan Drug (US) |
Start Date01 Apr 2015 |
Sponsor / Collaborator |
Start Date01 May 2013 |
Sponsor / Collaborator |
Start Date01 Apr 2010 |
Sponsor / Collaborator |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D10351 | - | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Locally Advanced Malignant Neoplasm | Phase 3 | US | 01 May 2013 | |
Pancreatic carcinoma non-resectable | Phase 3 | US | 01 May 2013 |
Study | Phase | Population | Analyzed Enrollment | Group | Results | Evaluation | Publication Date |
---|
Phase 3 | 303 | SOC+Algenpantucel-L | vpjuotguac(fgpurojuiu) = xadhvpwriw ckyhttehhl (uivmshpklg ) View more | Negative | 22 Dec 2020 | ||
SOC+Chemoradiotherapy | vpjuotguac(fgpurojuiu) = npjzwaxabb ckyhttehhl (uivmshpklg ) View more | ||||||
Phase 3 | - | Standard of Care+Algenpantucel-L | rnyiuxybir(kzsrypkojn) = jrotgmtinb ehmrjwhnpc (bjjdzawaov ) View more | Negative | 09 May 2016 | ||
Standard of Care | rnyiuxybir(kzsrypkojn) = mxvcujhgzc ehmrjwhnpc (bjjdzawaov ) View more |